Bioventus Inc. - Class A Common Stock (NQ:BVS)

13.52 +0.39 (+2.97%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Bioventus Reports First Quarter Financial Results

May 06, 2025

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

April 28, 2025

From Bioventus, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 07, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

August 04, 2025

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

July 30, 2025

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

July 29, 2025

From Bioventus, Inc.

Via GlobeNewswire

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Examining the Future: Bioventus's Earnings Outlook ↗

May 05, 2025

Via Benzinga

Gapping stocks in Tuesday's session ↗

March 11, 2025

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.

Via Chartmill

Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million ↗

March 11, 2025

Bioventus posted strong Q4 results, with EPS and revenue surpassing estimates. The company projects 2025 sales of $560M–$570M and adjusted EPS of $0.64–$0.68.

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

March 11, 2025

As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

Korn Ferry Posts Better-Than-Expected Earnings, Joins Bioventus, Endeavour Silver, Vail Resorts And Other Big Stocks Moving Higher On Tuesday ↗

March 11, 2025

Via Benzinga

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

March 11, 2025

From Bioventus, Inc.

Via GlobeNewswire

Earnings Scheduled For March 11, 2025 ↗

March 11, 2025

Via Benzinga

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

February 28, 2025

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 07, 2025

From Bioventus, Inc.

Via GlobeNewswire

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

January 02, 2025

From Bioventus, Inc.

Via GlobeNewswire

Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings ↗

November 05, 2024

Via Benzinga

Topics Stocks

S&P 500 Gains 1%; Vimeo Shares Spike Higher ↗

November 05, 2024

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 05, 2024

Via Benzinga

Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September ↗

November 05, 2024

Via Benzinga

Bioventus Reports Third Quarter Financial Results

November 05, 2024

From Bioventus, Inc.

Via GlobeNewswire

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

October 29, 2024

From Bioventus, Inc.

Via GlobeNewswire

Solventum Stock Earns 81 RS Rating ↗

October 15, 2024

Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.

Via Investor's Business Daily

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

October 01, 2024

From Bioventus, Inc.

Via GlobeNewswire

Executives Buying W. P. Carey And 2 Other Stocks ↗

August 21, 2024

Via Benzinga

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

August 07, 2024

From Bioventus, Inc.

Via GlobeNewswire

BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday ↗

August 06, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.